Rabbit anti-CFDP1 Antibody Affinity Purified
Product Details
Specifications
The epitope recognized by A305-653A maps to a region between residue 249 to 299 of human Craniofacial development protein 1 using the numbering given in entry Q9UEE9.1 (GeneID 10428).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4. Antibody was affinity purified using an epitope specific to CFDP1 immobilized on solid support.
The epitope recognized by A305-653A-T maps to a region between residue 249 to 299 of human Craniofacial development protein 1 using the numbering given in entry Q9UEE9.1 (GeneID 10428).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4.
Additional Product Information
Craniofacial development protein 1 (CFDP1) may play a role during embryogenesis [taken from the Universal Protein Resource (UniProt) www.uniprot.org/uniprot/Q9UEE9].
Alternate Names
BCNT; BUCENTAUR; CENP-29; centromere protein 29; CP27; craniofacial development protein 1; p97; phosphoprotein (Bucentaur); SWC5; Yeti
Applications
All western blot analysis is performed using 5% Milk-TBST for blocking and as antibody diluent. Primary antibody is incubated overnight.
Western blots of immunoprecipitates are performed using Goat anti-Rabbit Light Chain HRP Conjugate (Cat. No. A120-113P) with 5% Normal Pig Serum (Cat. No. S100-020) added to the blocking buffer.